EXOSOMES DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Exosomes Diagnostic and Therapeutic Market, By Type (Exosome Diagnostics and Exosome Therapeutics), By Product & Service (Instruments & Services and Kits & Reagents), By Source (Stem Cells, Blood & Blood Plasma, Urine, and Other Sources), By Application (Cancer, Dermatological Diseases, Musculoskeletal Disorders, Cardiovascular Diseases, and Others), By End User (Hospitals & Diagnostic Centers, Clinics and Physician Settings, Academic and Research Institutions, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In April 2021, Thermo Fisher Scientific launched the Thermo Scientific KingFisher Apex Purification System, a high-throughput tool designed to automate the extraction of RNA, DNA, cells, and proteins from various sample types. This system is intended to boost research productivity and accelerate discoveries by streamlining the sample preparation process.
In February 2022, Bio-Techne Corporation announced an agreement with Thermo Fisher Scientific, under which Thermo Fisher will assist Bio-Techne’s brand, Exosome Diagnostics, in developing and commercializing the ExoTRU kidney transplant rejection test.